Contents

Current Pharmaceutical Design, Volume 17 - Number 29

Editorial [Hot Topic: New Prospects for Treatment of Autoimmune Diseases (Executive Guest Editor: Alessandra Fierabracci)]

, 17(29): 3092 - 3093

Alessandra Fierabracci


DOI: 10.2174/138161211798157577




Experimental Strategies in Autoimmunity: Antagonists of Cytokines and their Receptors, Nanocarriers, Inhibitors of Immunoproteasome, Leukocyte Migration and Protein Kinases

, 17(29): 3094 - 3107

Alessandra Fierabracci and Emira Ayroldi


DOI: 10.2174/138161211798157586




Manipulating Thymic Apoptosis for Future Therapy of Autoimmune Diseases

, 17(29): 3108 - 3119

Domenico V. Delfino, Nicola Pozzesi, Sara Pierangeli, Emira Ayroldi and Alessandra Fierabracci


DOI: 10.2174/138161211798157621




Promising Pharmacological, Molecular and Cellular Treatments of Autoimmune Hepatitis

, 17(29): 3120 - 3140

Albert J. Czaja


DOI: 10.2174/138161211798157568




Anti-TNF Treatment in Rheumatoid Arthritis

, 17(29): 3141 - 3154

Janina Geiler, Maya Buch and Michael F. McDermott


DOI: 10.2174/138161211798157658




B Cell Modulation Strategies in Autoimmunity: The SLE Example

, 17(29): 3155 - 3165

M. Manuela Rosado, Andrea Picchianti Diamanti, Federica Capolunghi and Rita Carsetti


DOI: 10.2174/138161211798157612




Update on Intravenous Immunoglobulins (IVIg) Mechanisms of Action and Off- Label use in Autoimmune Diseases

, 17(29): 3166 - 3175

Uriel Katz, Yehuda Shoenfeld and Gisele Zandman-Goddard


DOI: 10.2174/138161211798157540




A Pathogenetic Approach to Autoimmune Skin Disease Therapy: Psoriasis and Biological Drugs, Unresolved Issues, and Future Directions

, 17(29): 3176 - 3190

Emira Ayroldi, Alessandra Bastianelli, Lorenza Cannarile, Maria Grazia Petrillo, Domenico V Delfino and Alessandra Fierabracci


DOI: 10.2174/138161211798157649




Novel Therapeutic Approaches to Autoimmune Demyelinating Disorders

, 17(29): 3191 - 3201

Lara Sanvito, Cris S. Constantinescu and Bruno Gran


DOI: 10.2174/138161211798157630




The Chemokine System as a Therapeutic Target in Autoimmune Thyroid Diseases: A Focus on the Interferon-γ Inducible Chemokines and their Receptor

, 17(29): 3202 - 3216

Mario Rotondi and Luca Chiovato


DOI: 10.2174/138161211798157559




Immunotherapy-Based Strategies for the Treatment of Autoimmune Diabetes: Searching for the Cure

, 17(29): 3217 - 3223

Brett E. Phillips and Massimo Trucco


DOI: 10.2174/138161211798157603




Clinical Update on the Use of Immuno Modulators (antiCD3, GAD, Diapep277, Anti-IL1) in Type 1 Diabetes

, 17(29): 3224 - 3228

Paolo Pozzilli, Chiara Guglielmi, Daria Maggi, Angela Carlone, Raffaella Buzzetti and Silvia Manfrini


DOI: 10.2174/138161211798157531




Stem Cell-Based Immunomodulation in Type 1 Diabetes: Beyond the Regenerative Approach

, 17(29): 3229 - 3242

Biancamaria Longoni and Franco Mosca


DOI: 10.2174/138161211798157595




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science